What is Leede Financial’s Forecast for QIPT FY2025 Earnings?

Quipt Home Medical Corp. (NASDAQ:QIPT) – Leede Financial reduced their FY2025 earnings per share estimates for shares of Quipt Home Medical in a note issued to investors on Wednesday, December 18th. Leede Financial analyst D. Loe now anticipates that the company will earn ($0.15) per share for the year, down from their prior estimate of ($0.03). The consensus estimate for Quipt Home Medical’s current full-year earnings is ($0.10) per share. Leede Financial also issued estimates for Quipt Home Medical’s FY2026 earnings at ($0.12) EPS.

Quipt Home Medical (NASDAQ:QIPT) last issued its quarterly earnings data on Monday, December 16th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.01 by ($0.08). Quipt Home Medical had a negative net margin of 1.95% and a negative return on equity of 4.51%.

Quipt Home Medical Price Performance

NASDAQ:QIPT opened at $2.49 on Friday. The company’s 50-day moving average is $2.68 and its two-hundred day moving average is $2.94. The firm has a market cap of $107.30 million, a price-to-earnings ratio of -22.64 and a beta of 0.62. Quipt Home Medical has a 12-month low of $2.30 and a 12-month high of $5.29. The company has a current ratio of 1.11, a quick ratio of 0.77 and a debt-to-equity ratio of 0.66.

Hedge Funds Weigh In On Quipt Home Medical

A number of hedge funds have recently bought and sold shares of QIPT. Forager Capital Management LLC lifted its holdings in Quipt Home Medical by 77.7% during the 3rd quarter. Forager Capital Management LLC now owns 4,192,562 shares of the company’s stock worth $12,200,000 after buying an additional 1,833,590 shares during the last quarter. Royce & Associates LP lifted its stake in Quipt Home Medical by 15.8% during the third quarter. Royce & Associates LP now owns 1,768,789 shares of the company’s stock worth $5,165,000 after purchasing an additional 240,980 shares during the last quarter. Verition Fund Management LLC boosted its holdings in Quipt Home Medical by 207.5% in the third quarter. Verition Fund Management LLC now owns 78,950 shares of the company’s stock worth $231,000 after purchasing an additional 53,275 shares during the period. Rhumbline Advisers boosted its holdings in Quipt Home Medical by 21.0% in the second quarter. Rhumbline Advisers now owns 49,276 shares of the company’s stock worth $159,000 after purchasing an additional 8,541 shares during the period. Finally, Bank of New York Mellon Corp raised its holdings in shares of Quipt Home Medical by 32.8% during the second quarter. Bank of New York Mellon Corp now owns 129,738 shares of the company’s stock worth $418,000 after purchasing an additional 32,073 shares during the period. 42.85% of the stock is currently owned by institutional investors and hedge funds.

Quipt Home Medical Company Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.